%0 Journal Article
%T Intratympanic dexamethasone for managing pregnant women with sudden hearing loss
%A Hui Zhao
%A Jianghua Jing
%A Tongli Ren
%A Yaoyao Fu
%J Journal of International Medical Research
%@ 1473-2300
%D 2019
%R 10.1177/0300060518802725
%X This study aimed to investigate the effect and safety of intratympanic dexamethasone in pregnant women with idiopathic sudden sensorineural hearing loss (ISSNHL). We performed a prospective study on pregnant women who suffered from ISSNHL and were treated in our clinic during 2016. The patients received intratympanic treatment three to four times a week. A pure tone audiogram (PTA) was performed before treatment and patients were followed up until 2 months after treatment was finished. A total of six pregnant women were included. All of the patients tolerated intratympanic treatment well. The mean improvement in hearing was 48£¿¡À£¿7.33 dB. There were no complications, including permanent perforation of the ear drum or middle ear infection. Each patient delivered a healthy newborn. Intratympanic dexamethasone is effective and safe for treating pregnant women with ISSNHL. Further randomized, controlled studies on this treatment need to be performed
%K Hearing loss
%K idiopathic sudden sensorineural hearing loss
%K dexamethasone
%K tympanic membrane
%K pregnant women
%K intratympanic steroid injection
%U https://journals.sagepub.com/doi/full/10.1177/0300060518802725